## Acute Opioid Overdose (Opioid Toxidrome) — Emergency Management **Key Point:** Acute opioid overdose is a medical emergency requiring immediate reversal with naloxone (a pure opioid antagonist) combined with supportive respiratory care. The classic triad is: **respiratory depression + pinpoint pupils + altered consciousness**. ### Recognition of Opioid Overdose This patient presents with the pathognomonic triad: 1. **Severe respiratory depression** (RR 6/min, SpO₂ 78%) — life-threatening. 2. **Pinpoint pupils** (miosis) — due to μ-opioid agonism in the midbrain. 3. **Altered consciousness** (GCS 6, unresponsive) — CNS depression. **High-Yield:** The combination of respiratory depression + miosis + coma in a known opioid user is diagnostic of opioid overdose until proven otherwise. ### Immediate Management Algorithm ```mermaid flowchart TD A["Opioid Overdose Suspected<br/>(RR <8, SpO₂ <90%, Pinpoint pupils)"]:::outcome A --> B["Immediate: Bag-and-Mask Ventilation<br/>or Nasal Cannula High-Flow O₂"]:::action B --> C["Establish IV Access"]:::action C --> D["Naloxone IV 0.4-2 mg<br/>Repeat q2-3 min if needed<br/>Max: 10 mg"]:::action D --> E{"Response to Naloxone?"}:::decision E -->|"Yes: Pupil dilation,<br/>Respiratory drive returns"| F["Monitor 4-6 hours<br/>Repeat naloxone if relapse<br/>Observe for withdrawal"]:::action E -->|"No: Still unresponsive<br/>RR <8"| G["Repeat naloxone 2 mg IV<br/>Consider intubation if<br/>airway compromise"]:::action G --> H{"Response?"}:::decision H -->|"Yes"| F H -->|"No"| I["Intubate & Ventilate<br/>Reassess diagnosis"]:::action ``` **Clinical Pearl:** Naloxone works within 1–2 minutes IV and has a shorter half-life (~60 min) than most opioids (heroin metabolite ~30 min, but morphine ~2–3 hours). Therefore, **relapse into overdose is common** and the patient must be monitored for at least 4–6 hours post-reversal. ### Why Naloxone First, Not Intubation First? **Naloxone is the definitive reversal agent** and should be given as soon as IV access is obtained, **in parallel with bag-and-mask ventilation**. The sequence is: 1. **Immediate:** Position patient, open airway, begin bag-and-mask ventilation (if trained) or high-flow O₂. 2. **Simultaneous:** Establish IV access. 3. **Immediate:** Administer naloxone 0.4–2 mg IV. 4. **Repeat:** Every 2–3 minutes up to 10 mg total if no response. 5. **Intubation:** Reserved for patients who do not respond to naloxone or have airway compromise (aspiration risk, absent gag reflex — as in this case). **Warning:** Do NOT delay naloxone to intubate. Naloxone is faster and safer than intubation alone. ### Naloxone Dosing and Administration | Route | Dose | Onset | Duration | Use | |-------|------|-------|----------|-----| | **IV** | 0.4–2 mg, repeat q2–3 min | 1–2 min | 30–90 min | **First-line** | | **IM/SC** | 0.4–2 mg | 2–5 min | 30–90 min | If no IV access | | **Intranasal** | 2 mg (0.1 mL of 20 mg/mL) | 2–3 min | 30–90 min | Lay-responder friendly | | **Intraosseous** | 0.4–2 mg | 1–2 min | 30–90 min | If no IV/IM access | **High-Yield:** Naloxone has **no abuse potential** (pure antagonist) and is safe to give empirically in any patient with suspected opioid overdose. There is no risk of overdosing with naloxone itself. ### Post-Reversal Management 1. **Observation:** Minimum 4–6 hours in ICU/monitored setting. 2. **Repeat naloxone:** If respiratory depression recurs (due to opioid's longer half-life). 3. **Withdrawal symptoms:** Patient may experience acute withdrawal (anxiety, agitation, diaphoresis, body aches) — this is uncomfortable but not life-threatening and resolves in hours. 4. **Addiction counseling:** Refer to de-addiction services; consider buprenorphine induction if patient consents. **Mnemonic:** **NARCAN** = **N**aloxone **A**ntagonizes **R**ecent **C**entral **A**ltered **N**eurological state. ## Why Each Distractor Is Wrong ### Distractor Analysis **Naltrexone (Option 3):** Naltrexone is a long-acting opioid antagonist (half-life ~10 hours) used for relapse prevention in opioid use disorder, NOT for acute overdose reversal. It is not available in IV formulation and would be too slow. Naloxone is the only appropriate acute reversal agent. **Epinephrine alone (Option 4):** Epinephrine is a sympathomimetic and does NOT reverse opioid effects. It may temporarily raise blood pressure and heart rate but will NOT restore respiratory drive or reverse CNS depression. The patient will continue to deteriorate without naloxone. **Intubation first (Option 2):** While intubation may be needed if naloxone fails or the patient has aspiration risk (absent gag reflex), it should NOT be the first step. Naloxone is faster, safer, and is the definitive treatment. Intubation is a bridge until naloxone works and carries risks (tube malposition, aspiration during intubation, sedation requirements). ## Summary The correct approach is **immediate bag-and-mask ventilation + IV naloxone 0.4–2 mg, repeated every 2–3 minutes as needed**. This reverses the opioid effect rapidly and safely. Intubation is reserved for patients who do not respond to naloxone or have airway compromise. [cite:NIDA Opioid Overdose Emergency Management; AHA ACLS Guidelines]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.